Filing Details

Accession Number:
0001209191-22-060700
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-12 16:30:29
Reporting Period:
2022-12-08
Accepted Time:
2022-12-12 16:30:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1841387 Candel Therapeutics Inc. CADL Biological Products, (No Disgnostic Substances) (2836) 522214851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1909680 Francesca Barone C/O Candel Therapeutics, Inc.
117 Kendrick St., Suite 450
Needham MA 02494
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-08 1,238 $1.61 2,738 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.